Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Ezetimibe on Risk of New-Onset Diabetes: A Systematic Review and Meta-Analysis of Large, Double-Blinded Randomized Controlled Trials
Chiu, Sarah W., Pratt, Cristina M., Feinn, Richard, Chatterjee, SauravJournal:
Journal of Cardiovascular Pharmacology and Therapeutics
DOI:
10.1177/1074248420924983
Date:
May, 2020
File:
PDF, 332 KB
2020